RECRUITING

Characterizing Sleep Among Long-term Survivors of Childhood Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The patients are being asked to take part in this clinical trial because they received cancer treatment as a child at St. Jude. The study comprehensively examines sleep among three distinct diagnostic groups of survivors in the SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors. Primary Objective The primary aim of this protocol is to estimate the prevalence of various sleep disorders among long-term survivors of childhood ALL, CNS tumors, and non- CNS solid tumors. Exploratory Objective The exploratory objective of the study is to explore associations between the prevalence of sleep disorders and clinical outcomes collected in SJLIFE.

Official Title

Characterizing Sleep Among Long-term Survivors of Childhood Cancer

Quick Facts

Study Start:2023-04-17
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05480904

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participant in SJLIFE and \> 5 years from diagnosis.
  2. * \>18 years of age at time of enrollment.
  3. * Diagnosed with ALL (treated with CRT or chemotherapy only) or CNS tumors (posterior fossa tumors or supratentorial tumors) or non-CNS solid tumors (with abdominal or chest radiation or bilateral retinoblastoma survivors).
  4. * Participant was less than 21 years of age at time of diagnosis.
  5. * Speaks and understands English (polysomnography device speaks to patients only in English).
  6. * Remote participant must have Wi-Fi access
  1. * Estimated intelligence score \<80.
  2. * Currently prescribed an intervention for a sleep disorder.
  3. * Survivor of craniopharyngioma.
  4. * Survivor of Hodgkin Lymphoma.
  5. * Relapsed or treated with hematopoietic stem cell therapy.
  6. * Brain injury unrelated to cancer diagnosis or therapy.
  7. * Pulmonary injury unrelated to cancer diagnosis or therapy.

Contacts and Locations

Study Contact

Kevin Krull, PhD
CONTACT
866-278-5833
referralinfo@stjude.org

Principal Investigator

Kevin Krull, PhD
PRINCIPAL_INVESTIGATOR
St. Jude Children's Research Hospital

Study Locations (Sites)

St. Jude Children's Research Hospital
Memphis, Tennessee, 38105
United States

Collaborators and Investigators

Sponsor: St. Jude Children's Research Hospital

  • Kevin Krull, PhD, PRINCIPAL_INVESTIGATOR, St. Jude Children's Research Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-17
Study Completion Date2025-12

Study Record Updates

Study Start Date2023-04-17
Study Completion Date2025-12

Terms related to this study

Additional Relevant MeSH Terms

  • ALL, Adult
  • CNS Tumor
  • Solid Tumor